[go: up one dir, main page]

HN1997000090A - Compuestos de piridilpirrol - Google Patents

Compuestos de piridilpirrol

Info

Publication number
HN1997000090A
HN1997000090A HN1997000090A HN1997000090A HN1997000090A HN 1997000090 A HN1997000090 A HN 1997000090A HN 1997000090 A HN1997000090 A HN 1997000090A HN 1997000090 A HN1997000090 A HN 1997000090A HN 1997000090 A HN1997000090 A HN 1997000090A
Authority
HN
Honduras
Prior art keywords
piridilpirrol
compounds
present
invention refers
refers
Prior art date
Application number
HN1997000090A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HN1997000090A publication Critical patent/HN1997000090A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A
HN1997000090A 1996-07-11 1997-06-18 Compuestos de piridilpirrol HN1997000090A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9600671 1996-07-11

Publications (1)

Publication Number Publication Date
HN1997000090A true HN1997000090A (es) 1997-12-26

Family

ID=11004451

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1997000090A HN1997000090A (es) 1996-07-11 1997-06-18 Compuestos de piridilpirrol

Country Status (14)

Country Link
US (1) US6417202B1 (es)
EP (1) EP0912548A1 (es)
AP (1) AP9701041A0 (es)
AR (1) AR007828A1 (es)
AU (1) AU3044197A (es)
BR (1) BR9710352A (es)
CA (1) CA2260213C (es)
HN (1) HN1997000090A (es)
HR (1) HRP970378A2 (es)
ID (1) ID19476A (es)
MA (1) MA26433A1 (es)
PA (1) PA8432901A1 (es)
TN (1) TNSN97119A1 (es)
WO (1) WO1998002430A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608060B1 (en) 1996-12-18 2003-08-19 Vertex Pharmaceuticals Incorporated Inhibitors of p38
US5945418A (en) * 1996-12-18 1999-08-31 Vertex Pharmaceuticals Incorporated Inhibitors of p38
US6147080A (en) * 1996-12-18 2000-11-14 Vertex Pharmaceuticals Incorporated Inhibitors of p38
PT853083E (pt) * 1997-01-06 2001-12-28 Pfizer Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica
FR2771412B1 (fr) * 1997-11-26 2000-04-28 Adir Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2316853A1 (en) * 1998-01-14 1999-07-22 Ayatsugu Nakamura Potassium channel activators
WO1999061016A1 (en) * 1998-05-27 1999-12-02 Nippon Shinyaku Co., Ltd. Cyclooxygenase-2 inhibitors
WO2000066124A1 (fr) * 1999-04-28 2000-11-09 Sankyo Company, Limited Agents preventifs ou inhibiteurs destines a une hepatopathie
WO2000069847A1 (en) * 1999-05-14 2000-11-23 Ortho-Mcneil Pharmaceutical, Inc. Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
AU7961100A (en) * 1999-10-28 2001-05-08 Daiichi Pharmaceutical Co., Ltd. Drug discharge pump inhibitors
GB0003154D0 (en) * 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
GB0016453D0 (en) 2000-07-04 2000-08-23 Hoffmann La Roche Pyrrole derivatives
EP1352906A4 (en) * 2001-01-18 2004-06-16 Sankyo Co COMPOSITIONS FOR PREVENTION OR TREATMENT OF LIVER DISEASES
EP1389463A4 (en) * 2001-04-26 2008-09-17 Daiichi Seiyaku Co MEDICAMENT FOR INHIBITING A DRUG REMOVAL PUMP
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
SE0102616D0 (sv) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
SE0102617D0 (sv) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
PL373115A1 (en) 2001-08-30 2005-08-08 F.Hoffmann-La Roche Ag Aminopyrrole compounds as antiinflammatory agents
MXPA05006569A (es) * 2002-12-20 2005-09-22 Pharmacia Corp Compuestos que inhiben la proteina cinasa-2 activada por la proteina cinasa activada por el mitogeno.
SE0300091D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300092D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
US20050043346A1 (en) * 2003-08-08 2005-02-24 Pharmacia Italia S.P.A. Pyridylpyrrole derivatives active as kinase inhibitors
JP2007523145A (ja) * 2004-02-20 2007-08-16 アストラゼネカ アクチボラグ ゴナドトロピン放出ホルモン（ｇｎｒｈ）アンタゴニストとしてのピロール誘導体
US7618982B2 (en) * 2005-12-19 2009-11-17 Nerviano Medical Sciences S.R.L. Heteroarylpyrrolopyridinones active as kinase inhibitors
CA2632565A1 (en) * 2005-12-19 2007-07-05 Syngenta Limited Substituted aromatic heterocyclic compounds as fungicides
US8263604B2 (en) * 2006-03-27 2012-09-11 Nerviano Medical Sciences S.R.L. Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
MX2009003081A (es) 2006-09-21 2009-04-01 Novartis Ag Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas.
CN104379573A (zh) * 2012-04-20 2015-02-25 艾伯维公司 异吲哚酮衍生物
CN104334526A (zh) 2012-04-20 2015-02-04 艾伯维公司 异吲哚酮衍生物
CN105164113B (zh) * 2013-03-12 2018-03-02 艾伯维公司 吡咯酰胺抑制剂
EP3157914B1 (en) 2014-06-17 2018-09-26 Bayer Pharma Aktiengesellschaft 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
CN108602820A (zh) * 2015-12-16 2018-09-28 拜耳制药股份公司 杂-1,5,6,7-四氢-4h-吲哚-4-酮类化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356897A (en) 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
WO1997005877A1 (en) * 1995-08-10 1997-02-20 Merck & Co., Inc. 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
AU699148B2 (en) 1995-08-10 1998-11-26 Merck & Co., Inc. 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
AU7482396A (en) * 1995-10-31 1997-05-22 Merck & Co., Inc. Substituted aryl pyrroles, compositions containing such compounds and methods of use
WO1997016426A1 (en) 1995-10-31 1997-05-09 Merck & Co., Inc. Substituted aryl pyrroles, compositions containing such compounds and methods of use
WO1997016442A1 (en) 1995-10-31 1997-05-09 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
US5776954A (en) * 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use

Also Published As

Publication number Publication date
AP9701041A0 (en) 1999-01-10
ID19476A (id) 1998-07-16
WO1998002430A1 (en) 1998-01-22
PA8432901A1 (es) 2000-05-24
AR007828A1 (es) 1999-11-24
US20020049235A1 (en) 2002-04-25
MA26433A1 (fr) 2004-12-20
CA2260213A1 (en) 1998-01-22
CA2260213C (en) 2005-03-29
BR9710352A (pt) 1999-08-17
AU3044197A (en) 1998-02-09
EP0912548A1 (en) 1999-05-06
US6417202B1 (en) 2002-07-09
TNSN97119A1 (fr) 2005-03-15
HRP970378A2 (en) 1998-08-31

Similar Documents

Publication Publication Date Title
HN1997000090A (es) Compuestos de piridilpirrol
HN1997000023A (es) Derivados de lactama
HN1997000166A (es) 1-arilpirazoles plaguicidas
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1997000126A (es) Derivados de indazol
HN1997000097A (es) Piridinas condensadas con heterociclicos
HN1998000132A (es) Combinaciones terapeuticas
HN1998000124A (es) Terapia de combinacion
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
HN1997000146A (es) Derivados de pirimidina biciclica condensada
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000036A (es) Compuesto de pirazina
HN1998000057A (es) Derivados de nicotinamida
HN1998000175A (es) Imidazotriazininas
HN1998003689A (es) Azetidinas
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998000158A (es) Isoquinolinas
HN1998000106A (es) Composiciones parenterales de alatroflaxacino
HN1998000028A (es) Otropisomeros de 3 heteroaril - 4 (3h) - quinazolinonas.
HN1998000199A (es) Agentes terapeuticos
HN1998000193A (es) Compuestos de triazina
HN1998000045A (es) Composiciones farmaceuticas
HN1998000102A (es) Composiciones solubilizadas de sertralina
HN1998000165A (es) Polimorfos dofetilina
HN1998000087A (es) Compuestos de amonio cuaternario